Drug ID:   | NPD1426 |
Drug Name:   | |
Molecular Formula:   | C14H22N4 |
Canonical SMILES:   | CCCN1CCC[C@H]2[C@H]1Cc1c[nH]c(=N)nc1C2 |
Standard InCHI:   | InChI=1S/C14H22N4/c1-2-5-18-6-3-4-10-7-12-11(8-13(10)18)9-16-14(15)17-12/h9-10,13H,2-8H2,1H3,(H2,15,16,17)/t10-,13-/m1/s1 |
Standard InCHIKey:   | TUFADSGTJUOBEH-ZWNOBZJWSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.6517 | NPC471868 |
Remote Similarity | 0.6386 | NPC472735 |
Remote Similarity | 0.622 | NPC477460 |
Remote Similarity | 0.622 | NPC76869 |
Remote Similarity | 0.6022 | NPC471867 |
Remote Similarity | 0.6 | NPC57599 |
Remote Similarity | 0.5814 | NPC472543 |
Remote Similarity | 0.5802 | NPC477459 |
Remote Similarity | 0.5802 | NPC477461 |
Molecular Weight   | 246.18 |
ALogP   | -1.4508 |
MLogP   | 2.56 |
XLogP   | 1.456 |
HDA   | 4 |
HBD   | 2 |
Rotatable Bonds   | 3 |
TPSA   | 51.48 |
RO5 Violation   | 0 |